PL9643

· Palatin Technologies, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PL9643, covering 2020-11-13 to 2024-10-17. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 3, Multi-Center Study Evaluating PL9643 in Patients with Dry Eye [Phase 3]